Clinical note
Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients

https://doi.org/10.1016/0168-8227(96)01216-8Get rights and content

Abstract

Chlamydia trachomatis oculogenital infection is a common disease in western societies. Despite the fact that diabetes is accompanied by increased risk for infections, no data on chlamydial infections in the non-insulin-dependent diabetic (NIDDM) patient exist. In our study Chlamydia antibodies were determined using an immunoperoxidase reaction in NIDDM patients (n = 79) and in a local nondiabetic control population (n = 125) which was randomly invited to a medical control visit without any preselection criteria. In total, 46% of diabetics and 55% of controls were IgG-Chlamydia antibody positive (ns). Using IgA-Chlamydia antibodies to define ‘seroactive’ chlamydial infection, 22% of NIDDM patients and 14% of controls were positive. Thus seroactive chlamydial infection of all patients with proven contact to Chlamydia (IgG-Chlamydia antibody positive) was 47% in diabetics versus 25% in controls, respectively (P < 0.05). Forming subgroups, significance was reached in females (52% vs. 32%, P < 0.05) only, but a similar trend was observed in males (36% vs. 21%, ns). Seroactivity was neither correlated with HbA1c nor with nephelometrically determined total serum immunoglobulins (IgG, IgA). Additionally we observed significantly elevated total IgM and IgA-levels in NIDDM patients whereas IgG-levels were comparable in both groups. In conclusion, seroactive chlamydial infections in subjects with proven contact to Chlamydia are more frequent in NIDDM patients than in nondiabetic controls. Additionally, higher IgM and IgA serum levels might indicate a higher susceptibility to active surface infections in NIDDM.

References (20)

  • E.J. Rayfield et al.

    Infection and diabetes: the case for glucose control

    Am. J. Med.

    (1982)
  • P. Saikku

    The epidemiology and significance of Chlamydia pneumoniae

    J. Infect.

    (1992)
  • H.H. Balch et al.

    Blood bactericidal studies and serum complement in diabetic patients

    J. Surg. Res.

    (1963)
  • H. Toplak et al.

    Diabetes mellitus und Infektionen

    Folia chemotherapeutica austriaca

    (1991)
  • H.D. Brede

    Chlamydien

    Münch. Med. Wochenschr.

    (1986)
  • F.N. Judson

    Assessing the number of genital chlamydial infections in the United States

    J. Reprod. Med.

    (1985)
  • J.D. Oriel et al.

    Genital infection by Chlamydia trachomatis

  • Centers for disease control

    Chlamydia trachomatis infections — policy guidelines for prevention and control

    Morbidity Mortality Weekly Rep.

    (1985)
  • E.M. Ehgartner et al.

    Serumantikörper gegen Chlamydia trachomatis bei Patienten ohne chlamydienspezifisches Krankheitsbild

    Fortschr. Ophthalmol.

    (1988)
  • B. Piura et al.

    Serum IgG and IgA antibodies specific for Chlamydia trachomatis in salpingitis patients as determined by the immunoperoxidase assay

    Eur. J. Epidemiol.

    (1985)
There are more references available in the full text version of this article.
View full text